Search

Your search keyword '"Gray, O"' showing total 1,008 results

Search Constraints

Start Over You searched for: Author "Gray, O" Remove constraint Author: "Gray, O"
1,008 results on '"Gray, O"'

Search Results

1. Machine-learning-based prediction of disability progression in multiple sclerosis: An observational, international, multi-center study

2. Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom

3. The risk of secondary progressive multiple sclerosis is geographically determined but modifiable

4. Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis

5. Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial

6. Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis

7. Comparative effectiveness in multiple sclerosis: A methodological comparison

8. Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis

9. Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis

10. Early non-disabling relapses are associated with a higher risk of disability accumulation in people with relapsing-remitting multiple sclerosis

11. A non-inferiority study of rituximab versus ocrelizumab in relapsing-remitting multiple sclerosis

12. Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study.

13. Confirmed disability progression as a marker of permanent disability in multiple sclerosis.

14. Confirmed disability progression as a marker of permanent disability in multiple sclerosis

16. Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years

17. Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis.

18. Variability of the Response to Immunotherapy among Sub-groups of Patients with Multiple Sclerosis.

19. Association of latitude and exposure to ultraviolet B radiation with severity of multiple sclerosis.

20. The MSBase pregnancy, neonatal outcomes, and women's health registry

21. The MSBase pregnancy, neonatal outcomes, and women’s health registry

22. Effect of disease modifying therapy on disability in Relapsing-Remitting multiple sclerosis over 15 Years

23. Predicting long-term sustained disability progression in multiple sclerosis.

24. Delay from treatment start to full effect of immunotherapies for multiple sclerosis

26. Finders, keepers?

27. Gender Inequities in the Multiple Sclerosis Community: A Call for Action

28. The Foreign Corrupt Trade Practices Act: revisited and amended

36. Contribution of different relapse phenotypes to disability in multiple sclerosis

45. Defining secondary progressive multiple sclerosis

46. The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis

47. Internal reporting - help or frustration?

48. Evaluation of common criteria of progression of disability in a large observational cohort

49. Effect of relapse phenotype on the accumulation of disability in relapsing-remitting multiple sclerosis

50. Defining reliable disability outcomes in multiple sclerosis

Catalog

Books, media, physical & digital resources